Internal Med. On Demand: Cardiometabolic Update Vol. 2
|
$399.20
Use promo code (Limited Time Offer)
15 CREDITS
  Hurry! Offer expires January 1, 202 at 11:59 pm ET!
|
|
A collection of recorded video lectures from recent conferencesCourse Content
| Session | Title | Faculty |
| Session 1 (75 minutes) | Treatment of T2DM: A Sound Approach Based Upon Its Pathophysiology | R. DeFronzo, MD |
| Session 2 (43 minutes) | Using Technology to Enhance Outpatient Type 2 Diabetes Treatment | J. Green, MD |
| Session 3 (48 minutes) | Update on the Diabetes Standards of Care | J. Green, MD |
| Session 4 (83 minutes) | Diabetes Cases | J. Green, MD & K. Pantalone, DO |
| Session 5 (65 minutes) | Focusing on the Use of GLP-1RA and SGLT2 Inhibitor Agents in Type 2 Diabetes | K. Pantalone, DO |
| Session 6 (48 minutes) | Lipid Lowering Therapies for Statins and PCSK9 Inhibitors to the Newest Agents | P. Taub, MD |
| Session 7 (72 minutes) | Lipid Cases | P. Taub, MD & J. Underberg, MD |
| Session 8 (40 minutes) | Addressing Residual Risk Beyond LDL Cholesterol with Focus on Triglycerides and Lipoprotein A | J. Underberg, MD |
| Session 9 (45 minutes) | Management of Familial Hypercholesterolemia | J. Underberg, MD |
| Session 10 (43 minutes) | Risk Assessment and Lipid Management in Cardiometabolic Disease | P. Taub, MD |
| Session 11 (51 minutes) | Key Pearls in Evaluating and Treating Hypertension | J. Basile, MD |
| Session 12 (45 minutes) | Endocrine Causes of Hypertension | R. Carey, MD |
| Session 13 (45 minutes) | Hypertension: What Have We Learned Since the Last Guideline | R. Carey, MD |
| Session 14 (97 minutes) | Hypertension Cases | J. Byrd, MD, J. Basile, MD, S. Taler, MD, & R. Carey, MD |
| Session 15 (49 minutes) | Resistant Hypertension: What the Future Holds | S. Taler, MD |
| Session 16 (49 minutes) | Diabetic Kidney Disease: An Update | S. Taler, MD |
Program Overview
Cardiometabolic disorders are a cluster of health conditions associated with cardiovascular disease and type 2 diabetes. It is estimated that over 1/3 of American’s suffer from a cardiometabolic disorder. The associated morbidity and mortality deserve increased clinical attention as we address risk factors predisposing individuals to these disorders. Internal Medicine On Demand: Cardiometabolic Update Volume 2 will address issues confronting the clinician who treats challenging patients with diabetes, hypertension, and dyslipidemia. This CME activity is comprised of recorded video lectures from recent conferences. The course will help identify these conditions and their related complications to enable clinicians to appropriately intervene with evidence-based treatments and risk-factor control while improving patient education.
Learning Objectives:
As a result of this educational activity, participants should be better able to:
- Diagnose and identify cardiometabolic risk factors, including diabetes, dyslipidemia, hypertension, and obesity.
- Integrate evidence-based strategies and recent guidelines for the screening, prevention, and treatment of cardiometabolic risk factors and their comorbidities in clinical practice.
- Incorporate appropriate interventions, including lifestyle modifications, nutrition counseling, and drug and surgical therapies, based on a specific patient’s risk profile.
Post-Test and Evaluation:
After completing the CME activity, you must successfully complete a post-test and fill out a program evaluation form. You will then be able to view and print your CME certificate. Login into CME365 to view your transcript and reprint your certificate at any time.
Faculty
Jan N. Basile, MD, FACP, FASH, FAHA
Professor of Medicine
Seinsheimer Cardiovascular Health Program
Medical University of South Carolina
Ralph H. Johnson VA Medical Center
Charleston, SC
J. Brian Byrd, MD
Assistant Professor of Medicine
Division of Cardiology
Department of Internal Medicine
University of Michigan School of Medicine
Ann Arbor, Michigan
Robert M. Carey, MD, MACP
Professor of Medicine
Emeritus, School of Medicine
University of Virginia
Charlottesville, VA
Ralph A. DeFronzo, MD
Professor of Medicine
Chief, Diabetes Division
University of Texas Health Science Center
Deputy Director, Texas Diabetes Institute
San Antonio, TX
Jennifer Green, MD
Professor of Medicine
Duke University Medical Center
Division of Endocrinology
Durham VA Medical Center
Durham, NC
Kevin M. Pantalone, DO, ECNU, FACE
Staff Endocrinologist
Director of Diabetes Initiatives
Department of Endocrinology
Cleveland Clinic
Cleveland, OH
Sandra J. Taler, MD, FACP, FAHA
Professor of Medicine
Division of Nephrology and Hypertension
Mayo Clinic
Rochester, MN
Pam R. Taub, MD, FACC, FAPSC
Associate Professor of Medicine
University of California San Diego School of Medicine
Founding Director of the Step Family Foundation Cardiac Rehabilitation and Wellness Center
San Diego, CA
James A. Underberg, MD, MS, FACPM, FACP, FNYAM, FASPC, FNLA
Lipidology & Cardiovascular Disease Prevention
Diplomate American Board of Clinical Lipidology
Clinical Assistant Professor of Medicine
NYU Medical School & NYU Center for CV Prevention
Director, Bellevue Hospital Lipid Clinic
Past-President National Lipid Association
President American Board of Clinical Lipidology
New York, NY
Accreditation
AMA PRA Category 1 Credits™: Continuing Education Company, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Continuing Education Company designates this enduring material for a maximum of 15 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 15 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Please allow 6-8 weeks for your MOC points to appear on your ABIM records.
AAPA: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 15 hours of Category 1 credit for completing this activity.
AANPCB: The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Nurse Practitioners may receive a maximum of 15 hours of participation, 11 of which can be used towards Pharmacology, for completing this activity.
Release Date: 9/30/2022
Expiration Date: 9/30/2025 (Date after which this enduring material is no longer certified for credit.)
Medium: Internet/Enduring Material, Video/Audio
Faculty/Planning Committee Disclosures
Review and Planning Committee Disclosures:
The following individuals have indicated that he/she (nor spouse/partner) has no relevant financial relationships with a commercial interest that may impact upon this CME activity:
- Raymond E. Major - Reviewer
- Walter Ejnes, CHCP - Reviewer & Planning Committee (Continuing Education Company)
- Beth Townsend - Reviewer (Continuing Education Company)
- Su Barnwell - Planning Committee (Continuing Education Company)
Faculty Disclosures:
The following individuals have indicated that he/she (nor spouse/partner) have no relevant financial relationships with a commercial interest that may impact upon this CME activity:
| Faculty | Disclosure |
| Jan N. Basile, MD | Consultant: Medtronic, Medtronic Adjudication Committee and Up-to-Date (Hypertension Section) Research Grant: Ablative Solutions (Target BP I), ReCor (RADIANCE I and II), and Eli Lilly |
| J. Brian Byrd, MD | Consultant: HealthXL and Nonin Advisory Board: Phase Bio |
| Robert Carey, MD | Research Grant (payments to Univ. of Virginia): NIH (R01) and NIH (P01) |
| Ralph DeFronzo, MD | Advisory Board: Intarcia Therapeutics Advisory Board, Honorarium: Poxel Advisory Board, Research Grant: Boehringer Ingelheim and Janssen Advisory Board, Research Grant, Speakers Bureau: Astra Zeneca Advisory Board, Speakers Bureau: Novo Nordisk Research Grant: Merck |
| Jennifer Green, MD | Consultant: Astra Zeneca, Hawthorne Effect/Omada, Novo Nordisk, and Pfizer Consultant, Research Grant: Boehringer Ingelheim Research Grant: Merck and Roche |
| Kevin Pantalone, DO | Consultant: DIASOME, Eli Lilly and Sanofi Consultant, Research Grant: Bayer Consultant, Speakers Bureau: Astra Zeneca and Corcept Therapeutics Consultant, Research Grant, Speaker Bureau: Merck and Novo Nordisk |
| Sandra Taler, MD | Nothing to Disclose |
| Pam Taub, MD | Advisory Board, Consultant: Amgen, Bayer, Boehringer Ingelheim, Esperion, Novo Nordisk, and Sanofi Grant Recipient: American Heart Association and FEMA Research Grant: National Institute of Health (NIH) R01 Shareholder:Empirium Bio |
| James Underberg, MD | Advisory Board: Novartis Advisory Board, Consultant, Honoraria, Speakers Bureau: Amgen Advisory Board, Research Grant, Speakers Bureau: Amryt Advisory Bureau, Speakers Bureau: Alexion, Esperion, and Regeneron |
Unlabeled Use Declaration:
During their presentation, faculty may discuss unlabeled or investigational use which is not approved for a commercial product. Faculty members are required to disclose this information to the audience when referring to an unlabeled or investigational use.
Statement of Disclosure and Independence:
It is the policy of Continuing Education Company (CEC) to ensure all of its accredited educational activities are designed, implemented, and evaluated in accordance with the Accreditation Council for Continuing Medical Education’s (ACCME) Criteria and Policies. In accordance with ACCME requirements, CEC has Relevant Financial Relationship Disclosure Policies that are designed to ensure that accredited educational activities are fair, balanced, independent, evidence based, and based on scientific rigor.
All individuals who are in position to influence and/or control content of a CEC accredited Continuing Medical Education (CME) activity must disclose any relevant financial interest or other relationships they have with an ineligible company, which is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. (Relevant financial interest or other relationship includes such things as grants or research support, employee, consultant, major stockholder, member of speakers’ bureau, etc.) The intent of this disclosure is to provide activity participants with information to determine whether the speaker’s interests or relationships may influence the presentation with regard to exposition or conclusions. All relevant financial relationships have been identified, mitigated, and are listed above.
The opinions, ideas, recommendations, and perspectives expressed in the syllabus and accompanying presentations at this activity are those of the program authors and presenting faculty only and do not necessarily reflect the opinions, ideas, recommendations or perspectives of their affiliated institutions, Continuing Education Company, advisory boards or consultants.
Computer Requirements
Flash Player 10 or later, and one of the following browsers:
- Windows: Internet Explorer 6 and later, Microsoft Edge (latest version), Firefox 1.x and later, Google Chrome (latest version), Opera 9.5 and later
- Mac: Safari 3 and later, Firefox 1.x and later, Google Chrome (latest version)
- Linux: Firefox 1.x and later
HTML5 via one of the following browsers:
- Windows: Google Chrome (latest version)
- Mac: Safari 6.0.5 or later, Google Chrome (latest version)
- Mobile: Safari in Apple iOS 6 or later
30 Day Money Back Guarantee
CEC stands behind our product. If you are not satisfied with your online course for any reason, send a written cancellation request and reason to registration@cmemeeting.org within 30 days of the purchase date for a full refund. (Cancellations on CME365™ Collection Series will incur a 5% processing fee.) Please note you may watch any of the content but once you claim credit for any online course, no refund can be granted.